Neutrophil extracellular traps contribute to myofibroblast differentiation and scar hyperplasia through the Toll-like receptor 9/nuclear factor Kappa-B/interleukin-6 pathway

Yiming Shao , Zaiwen Guo , Yunxi Yang , Lu Liu , Jiamin Huang , Yi Chen , Linbin Li , Bingwei Sun

Burns & Trauma ›› 2022, Vol. 10 ›› Issue (1) : tkac044

PDF (2613KB)
Burns & Trauma ›› 2022, Vol. 10 ›› Issue (1) :tkac044 DOI: 10.1093/burnst/tkac044
Research Article
research-article
Neutrophil extracellular traps contribute to myofibroblast differentiation and scar hyperplasia through the Toll-like receptor 9/nuclear factor Kappa-B/interleukin-6 pathway
Author information +
History +
PDF (2613KB)

Abstract

Background: Inflammation is an important factor in pathological scarring. The role of neutrophils, one of the most important inflammatory cells, in scar hyperplasia remains unclear. The purpose of this article is to study the correlation between neutrophil extracellular traps (NETs) and scar hyperplasia and identify a new target for inhibiting scar hyperplasia. Methods: Neutrophils were isolated from human peripheral blood by magnetic-bead sorting. NETs in plasma and scars were detected by enzyme-linked immunosorbent assays (ELISAs), immunofluorescence and flow cytometry. Immunohistochemistry was used to assess neutrophil (CD66B) infiltration in hypertrophic scars. To observe the entry of NETs into fibroblasts we used immunofluorescence and flow cytometry. Results: We found that peripheral blood neutrophils in patients with hypertrophic scars were more likely to form NETs (p < 0.05). Hypertrophic scars showed greater infiltration with neutrophils and NETs (p < 0.05). NETs activate fibroblasts in vitro to promote their differentiation and migration. Inhibition of NETs with cytochalasin in wounds reduced the hyperplasia of scars in mice. We induced neutrophils to generate NETs with different stimuli in vitro and detected the proteins carried by NETs. We did not find an increase in the expression of common scarring factors [interleukin (IL)-17 and transforming growth factor-β (TGF-β), p > 0.05]. However, inhibiting the production of NETs or degrading DNA reduced the differentiation of fibroblasts into myofibroblasts. In vitro, NETs were found to be mediated by Toll-like receptor 9 (TLR-9) in fibroblasts and further phosphorylated nuclear factor Kappa-B (NF-κB). We found that IL-6, which is downstream of NF-κB, was increased in fibroblasts. Additionally, IL-6 uses autocrine and paracrine signaling to promote differentiation and secretion. Conclusions: Our experiments found that NETs activate fibroblasts through the TLR-9/NF-κB/IL-6 pathway, thereby providing a new target for regulating hypertrophic scars.

Keywords

Neutrophil extracellular traps / Hypertrophic scar / Toll-like receptor 9 / Fibroblast / Inflammation / Differentiation / Nuclear factor Kappa-B / Interleukin-6

Cite this article

Download citation ▾
Yiming Shao, Zaiwen Guo, Yunxi Yang, Lu Liu, Jiamin Huang, Yi Chen, Linbin Li, Bingwei Sun. Neutrophil extracellular traps contribute to myofibroblast differentiation and scar hyperplasia through the Toll-like receptor 9/nuclear factor Kappa-B/interleukin-6 pathway. Burns & Trauma, 2022, 10 (1) : tkac044 DOI:10.1093/burnst/tkac044

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Monstrey S, Middelkoop E, Vranckx JJ, Bassetto F, Ziegler UE, Meaume S, et al. Updated scar management practical guidelines: non-invasive and invasive measures. J Plast Reconstr Aesthet Surg. 2014; 67: 1017-25.

[2]

Elsaie ML. Update on management of keloid and hypertrophic scars: a systemic review. J Cosmet Dermatol. 2021; 20: 2729-38.

[3]

Ogawa R.Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017; 18: 606. https://doi.org/10.3390/ijms18030606.

[4]

Wang ZC, Zhao WY, Cao Y, Liu YQ, Sun Q, Shi P, et al. The roles of inflammation in keloid and hypertrophic scars. Front Immunol. 2020; 11: 603187.

[5]

Fischer A, Wannemacher J, Christ S, Koopmans T, Kadri S, Zhao J, et al. Neutrophils direct preexisting matrix to initiate repair in damaged tissues. Nat Immunol. 2022; 23: 518-31.

[6]

Ren H, Zhao F, Zhang Q, Huang X, Wang Z. Autophagy and skin wound healing. Burns Trauma. 2022; 10: tkac003. https://doi.org/10.1093/burnst/tkac003.

[7]

Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004; 303: 1532-5.

[8]

Oklu R, Sheth RA, Wong KHK, Jahromi AH, Albadawi H. Neutrophil extracellular traps are increased in cancer patients but does not associate with venous thrombosis. Cardiovasc Diagn Ther. 2017; 7: S140-9.

[9]

Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013; 5: 178ra140. https://doi.org/10.1126/scitranslmed.3005580.

[10]

Tang S, Zhang Y, Yin SW, Gao XJ, Shi WW, Wang Y, et al. Neutrophil extracellular trap formation is associated with autophagy-related signalling in ANCA-associated vasculitis. Clin Exp Immunol. 2015; 180: 408-18.

[11]

Yipp BG, Petri B, Salina D, Jenne CN, Scott BN, Zbytnuik LD, et al. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat Med. 2012; 18: 1386-93.

[12]

Shao Y, Li L, Liu L, Yang Y, Huang J, Ji D, et al. CD44/ERM/F-actin complex mediates targeted nuclear degranulation and excessive neutrophil extracellular trap formation during sepsis. J Cell Mol Med. 2022; 26: 2089-103.

[13]

Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One. 2012; 7: e32366. https://doi.org/10.1371/journal.pone.0032366.

[14]

Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol. 2011; 187: 538-52.

[15]

Kolaczkowska E, Jenne CN, Surewaard BG, Thanabalasuriar A, Lee WY, Sanz MJ, et al. Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature. Nat Commun. 2015; 6: 6673. https://doi.org/10.1038/ncomms7673.

[16]

Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 2009; 5: e1000639. https://doi.org/10.1371/journal.ppat.1000639.

[17]

Mohanty T, Sjogren J, Kahn F, Abu-Humaidan AH, Fisker N, Assing K, et al. A novel mechanism for NETosis provides antimicrobial defense at the oral mucosa. Blood. 2015; 126: 2128-37.

[18]

Petretto A, Bruschi M, Pratesi F, Croia C, Candiano G, Ghiggeri G, et al. Neutrophil extracellular traps (NET) induced by different stimuli: a comparative proteomic analysis. PLoS One. 2019; 14: e0218946. https://doi.org/10.1371/journal.pone.0218946.

[19]

Kawabata K, Hagio T, Matsuoka S. The role of neutrophil elastase in acute lung injury. Eur J Pharmacol. 2002; 451: 1-10.

[20]

Aratani Y. Myeloperoxidase: its role for host defense, inflammation, and neutrophil function. Arch Biochem Biophys. 2018; 640: 47-52.

[21]

Tonello S, Rizzi M, Migliario M, Rocchetti V, Reno F. Low concentrations of neutrophil extracellular traps induce proliferation in human keratinocytes via NF-kB activation. J Dermatol Sci. 2017; 88: 110-6.

[22]

Chrysanthopoulou A, Mitroulis I, Apostolidou E, Arelaki S, Mikroulis D, Konstantinidis T, et al. Neutrophil extracellular traps promote differentiation and function of fibroblasts. J Pathol. 2014; 233: 294-307.

[23]

Shahar I, Fireman E, Topilsky M, Grief J, Kivity S, Spirer Z, et al. Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases. Clin Immunol Immunopathol. 1996; 79: 244-51.

[24]

Tan PL, Farmiloe S, Yeoman S, Watson JD. Expression of the interleukin 6 gene in rheumatoid synovial fibroblasts. J Rheumatol. 1990; 17: 1608-12.

[25]

Feghali CA, Bost KL, Boulware DW, Levy LS. Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis. Autoimmunity. 1994; 17: 309-18.

[26]

Abdu Allah AMK, Mohammed KI, Farag AGA, Hagag MM, Essam M, Tayel NR. Interleukin-6 serum level and gene polymorphism in keloid patients. Cell Mol Biol (Noisy-le-grand). 2019; 65: 43-8.

[27]

Tosa M, Watanabe A, Ghazizadeh M. IL-6 polymorphism and susceptibility to keloid formation in a Japanese population. J Invest Dermatol. 2016; 136: 1069-72.

[28]

Ghazizadeh M. Essential role of IL-6 signaling pathway in keloid pathogenesis. J Nippon Med Sch. 2007; 74: 11-22.

[29]

Ghazizadeh M, Tosa M, Shimizu H, Hyakusoku H, Kawanami O. Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol. 2007; 127: 98-105.

[30]

Zhang M, Zhang M, Zhou T, Liu M, Xia N, Gu M, et al. Inhibition of fibroblast IL-6 production by ACKR4 deletion alleviates cardiac remodeling after myocardial infarction. Biochem Biophys Res Commun. 2021; 547: 139-47.

[31]

Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020; 5:e138999.

[32]

Abu Abed U, Brinkmann V. Immunofluorescence labelling of human and murine neutrophil extracellular traps in paraffin-embedded tissue. J Vis Exp. 2019; 151: e60115.

[33]

Li X, He M, He H. Treatment of wound healing with sequential therapy to accelerate recovery and inhibit scar hyperplasia: a case report. Clin Cosmet Investig Dermatol. 2021; 14: 821-5.

[34]

Moore EM, Wagner C, Komarnytsky S. The enigma of bioactivity and toxicity of botanical oils for skin care. Front Pharmacol. 2020; 11: 785.

[35]

Jiang D, Rinkevich Y. Scars or regeneration?-dermal fibroblasts as drivers of diverse skin wound responses. Int J Mol Sci. 2020; 21: 617. https://doi.org/10.3390/ijms21020617.

[36]

Karvonen HM, Lehtonen ST, Harju T, Sormunen RT, Lappi-Blanco E, Makinen JM, et al. Myofibroblast expression in airways and alveoli is affected by smoking and COPD. Respir Res. 2013; 14: 84.

[37]

Zhao R, Liang H, Clarke E, Jackson C, Xue M. Inflammation in chronic wounds. Int J Mol Sci. 2016; 17: 2085. https://doi.org/10.3390/ijms17122085.

[38]

Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008; 453: 314-21.

[39]

Yu Y, Sun B. Autophagy-mediated regulation of neutrophils and clinical applications. Burns Trauma. 2020; 8: tkz001. https://doi.org/10.1093/burnst/tkz001.

[40]

Negreros M, Flores-Suarez LF. A proposed role of neutrophil extracellular traps and their interplay with fibroblasts in ANCA-associated vasculitis lung fibrosis. Autoimmun Rev. 2021; 20: 102781.

[41]

Abi Abdallah DS, Lin C, Ball CJ, King MR, Duhamel GE, Denkers EY. Toxoplasma gondii triggers release of human and mouse neutrophil extracellular traps. Infect Immun. 2012; 80: 768-77.

[42]

Branzk N, Lubojemska A, Hardison SE, Wang Q, Gutierrez MG, Brown GD, et al. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat Immunol. 2014; 15: 1017-25.

[43]

Nakazawa D, Kumar SV, Marschner J, Desai J, Holderied A, Rath L, et al. Histones and neutrophil extracellular traps enhance tubular necrosis and remote organ injury in ischemic AKI. J Am Soc Nephrol. 2017; 28: 1753-68.

[44]

Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018; 18: 134-47.

[45]

Sorensen OE, Borregaard N. Neutrophil extracellular traps-the dark side of neutrophils. J Clin Invest. 2016; 126: 1612-20.

[46]

Costa TJ, Potje SR, Fraga-Silva TFC, da Silva-Neto JA, Barros PR, Rodrigues D, et al. Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage. Vasc Pharmacol. 2022; 142: 106946.

[47]

Liu Y, Yan W, Tohme S, Chen M, Fu Y, Tian D, et al. Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through toll-like receptor 9. J Hepatol. 2015; 63: 114-21.

[48]

Kawai T, Akira S. Signaling to NF-kappaB by toll-like receptors. Trends Mol Med. 2007; 13: 460-9.

[49]

Song S, Chu L, Liang H, Chen J, Liang J, Huang Z, et al. Protective effects of...

PDF (2613KB)

39

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉